Ranked by rounds participated in, from announcements in Jul 18, 2026 – Oct 15, 2026. Lead counts include only confirmed lead roles.
New companies 10 · Follow-on 0
Stages: Series B 4, Series C+ 3, Series A 2, Seed 1
BigHat Biosciences $75M Series CCircle Pharma, Inc. $92.5M Series EMoonwalk Biosciences $70M Series BNew companies 8 · Follow-on 0
Stages: Series A 3, Series C+ 3, Series B 1, Undisclosed 1
Circle Pharma, Inc. $92.5M Series ESolstice Oncology $225M Series ASuperluminal Medicines $60M Series BNew companies 6 · Follow-on 0
Stages: Seed 4, Series A 2
Molagri Undisclosed SeedSensible Biotechnologies $47M Series AWonderTx $125K SeedNew companies 6 · Follow-on 0
Stages: Series C+ 4, Series B 2
BigHat Biosciences $75M Series CBasecamp Research $140M Series CEnveda $311M Series ENew companies 5 · Follow-on 0
Stages: Seed 2, Series C+ 2, Series A 1
OMass Therapeutics $310M Series CReEmerge, Inc. $37M Series AVivid Dx $15M SeedNew companies 4 · Follow-on 0
Stages: Series C+ 3, Series B 1
OMass Therapeutics $310M Series CSoufflé Therapeutics $135M Series BEncoded Therapeutics Inc. $275M Series FNew companies 3 · Follow-on 1
Stages: Series B 2, Series A 1, Series C+ 1
OMass Therapeutics $310M Series CAnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 4 · Follow-on 0
Stages: Series C+ 3, Series B 1
OMass Therapeutics $310M Series CAbcuro $66M Series DEpicrispr Biotechnologies $90M Series CNew companies 4 · Follow-on 0
Stages: Series B 2, Seed 1, Undisclosed 1
OlsAro €5M SeedAnaCardio €62.5M Series BEnginZyme SEK 75M Equity roundNew companies 4 · Follow-on 0
Stages: Series B 2, Series C+ 1, Undisclosed 1
Soufflé Therapeutics $135M Series BEncoded Therapeutics Inc. $275M Series FMoonwalk Biosciences $70M Series BNew companies 3 · Follow-on 0
Stages: Series C+ 2, Series A 1
OMass Therapeutics $310M Series CSling Therapeutics, Inc. $123M Series CSolstice Oncology $225M Series ANew companies 3 · Follow-on 0
Stages: Series C+ 2, Undisclosed 1
OMass Therapeutics $310M Series CEncoded Therapeutics Inc. $275M Series FLifeMine Therapeutics $263M Series D+Series ENew companies 3 · Follow-on 0
Stages: Seed 3
Undecimal Bio $18M SeedAptadir Therapeutics €40M SeedCloverleaf Bio $33M SeedNew companies 3 · Follow-on 0
Stages: Series B 1, Series C+ 1, Undisclosed 1
Soufflé Therapeutics $135M Series BEncoded Therapeutics Inc. $275M Series FLifeMine Therapeutics $263M Series D+Series ENew companies 3 · Follow-on 0
Stages: Series B 1, Series C+ 1, Undisclosed 1
Boltz Undisclosed Planned strategic investmentBasecamp Research $140M Series CSuperluminal Medicines $60M Series BNew companies 3 · Follow-on 0
Stages: Series A 2, Undisclosed 1
Edonia €15M Series A financing package including non-dilutive and bank fundingOne Biosciences €3.3M i-Démo 5 grant (France 2030)Brenus Pharma €11M Series ANew companies 3 · Follow-on 0
Stages: Series A 1, Series B 1, Series C+ 1
BigHat Biosciences $75M Series CLeal Therapeutics $30M Series AKhartis Therapeutics $50M Series BNew companies 3 · Follow-on 0
Stages: Series C+ 2, Undisclosed 1
BigHat Biosciences $75M Series CBasecamp Research $140M Series CNetwork Bio $50M StrategicNew companies 3 · Follow-on 0
Stages: Series A 2, Undisclosed 1
Novadip Biosciences €10.4M Convertible financingAmyl Therapeutics €8.3M Series A extensionBrenus Pharma €11M Series ANew companies 3 · Follow-on 0
Stages: Series A 1, Series B 1, Series C+ 1
Circle Pharma, Inc. $92.5M Series ELeal Therapeutics $30M Series AInduPro $77M Series BNew companies 3 · Follow-on 0
Stages: Series A 2, Series C+ 1
AusperBio $120M Series CBeyang Therapeutics $30M Series ACORE Biomedicine $21M Series ANew companies 2 · Follow-on 0
Stages: Series C+ 2
OMass Therapeutics $310M Series CAbcuro $66M Series DNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
OlsAro €5M SeedAquaNab Undisclosed UndisclosedNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Soufflé Therapeutics $135M Series BBigHat Biosciences $75M Series CNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Soufflé Therapeutics $135M Series BNetwork Bio $50M StrategicNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Soufflé Therapeutics $135M Series BEpicrispr Biotechnologies $90M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Soufflé Therapeutics $135M Series BRobigo Undisclosed Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Undecimal Bio $18M SeedShennon Biotechnologies $12M FundingNew companies 2 · Follow-on 0
Stages: Series B 2
Soufflé Therapeutics $135M Series BInduPro $77M Series B“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.